Use of artificial nutrition near the end of life: Results from a French national population-based study of hospitalized cancer patients.

This study indicates that the use of artificial nutrition near the end of life is in keeping with current clinical guidelines. The identification of factors associated with the use of artificial nutrition, such as cancer localization, presence of comorbidities or specific symptoms, may help to better manage its use.